2024 ICD-10-CM Diagnosis Code B60.12

by

Conjunctivitis due to Acanthamoeba

  • B60.12 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B60.12 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B60.12 – other international versions of ICD-10 B60.12 may differ.

The following code(s) above B60.12 contain annotation back-references

 that may be applicable to B60.12:

  • A00-B99  Certain infectious and parasitic diseases
  • B50-B64  Protozoal diseases
  • B60  Other protozoal diseases, not elsewhere classified

Approximate Synonyms

  • Bilateral conjunctivitis due to acanthamoeba
  • Left conjunctivitis due to acanthamoeba
  • Right conjunctivitis due to acanthamoeba

ICD-10-CM B60.12 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 124 Other disorders of the eye with mcc or thrombolytic agent
  • 125 Other disorders of the eye without mcc

Convert B60.12 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to B60.12: